Abiomed founder, cardiovascular pioneer, dies of cancer

August 20, 2012 by MassDevice staff

David Lederman, Abiomed founder and developer of the 1st fully implantable, battery-powered artificial heart, died last week at the age of 68 from pancreatic cancer.

Abiomed founder David Lederman

Abiomed (NSDQ:ABMD) founder and cardiovascular pioneer David Lederman last week died of pancreatic cancer at the age of 68.

At his funeral in Swampscott, Mass., mourners remembered Lederman as a scientist and author, as well as a humanitarian who sponsored a summer camp for children in Israel whose hometown was under attack from rockets from Gaza, the Boston Herald reported.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.